Assignee
HARBINGER HEALTH INC
US·1 granted patent·12 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
13 records- 0179US2026015678A1Tiered testing for high risk populationsHARBINGER HEALTH INC·Filed 2025·Application pending·0 cites
- 0275US2024309355A1Solid phase negative enrichmentHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 0375US2024309438A1Rare nucleic acid detectionHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 0474US2024327900A1Bodily fluid target enrichmentHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 0572US2024209427A1Rare nucleic acid detectionHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 0672US2024200122A1Bodily fluid target enrichmentHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 0772US2024209348A1Solid phase negative enrichmentHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 0870US2024309434A1Targeted rare allele crispr enrichmentHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 0968US2024052396A1Selective protection of nucleic acidsHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 1068US2024167076A1Selective enrichmentHARBINGER HEALTH INC·Filed 2023·Application pending·0 cites
- 1161US2025223652A1Tiered testing for high risk populationsHARBINGER HEALTH INC·Filed 2025·Application pending·0 cites
- 1256US12522865B2Nucleic acid enrichment methodHARBINGER HEALTH INC·Filed 2021·Granted Jan 13, 2026·0 cites·24 claims
- 1341US2025223632A1Probe blockers for enrichment of target nucleic acid sequencesHARBINGER HEALTH INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HARBINGER HEALTH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →